8
Total investments
2
Early stage
4
Mid stage
1
Late stage
31y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Feb 2025
CELCORE is a Danish life-science company at the
forefront of aesthetic medicine.
Our mission is to revolutionize skin rejuvenation by addressing aging at its biological core – rebuilding the skin’s natural framework at a cellular level for lasting results that go beyond temporary volume.
From our EU-licensed Tissue Establishment near Copenhagen, we harness the remarkable regenerative properties of human adipose tissue through two groundbreaking technology platforms.
ECM Technology Platform: Transforming adipose tissue into injectable treatments rich in collagen, elastin, and vital proteins for natural skin regeneration
Stem Cell Platform: Isolating and expanding mesenchymal stem cells for enhanced fat transfer procedures and research applications
Our proprietary technologies unlock the extraordinary potential of adipose tissue, creating advanced solutions for aesthetic medicine.
Seed Investor
Jun 2023
Copenhagen Nanosystems (cphnano.com) is a Danish Labtech company that develops solutions for particle size analysis and UV-Vis spectroscopy.
We work with upgrading UV-Vis spectrophotometry across all brands to be at the forefront at the technology development.
We expand the functionality of existing spectrophotometers by developing plastic labware with nanotechnology and analyzing data in the cloud - leading to faster and more accurate results in the laboratory while lowering upfront investments.
The NanoCuvettes™ unlocks the full potential of the spectrophotometer and SpectroWorks™ optimizes and automizes your UV-Vis instrument workflow.
Seed Investor
Nov 2022
GO-Pen is developing an affordable, reliable and sustainable insulin pen.
Our vision is to make a difference for the millions of people living with diabetes who currently cannot afford modern devices.
S
Seed Investor
Aug 2020
We are on a mission to reinvent the microelectrochemical sensor and change the way hydrogen sulfide is reliably measured in industrial applications.
The SulfiLogger™ sensor provides the insights you need to take your H₂S management to the next level. Using these insights, you can optimize mitigation activities and better account for H₂S in the planning of sewer infrastructure projects.
The SulfiLogger™ sensor is the only affordable sensor that measures H₂S continuously in untreated wastewater and in wet process gases. It represents a radically new approach to measuring and monitoring H₂S in harsh environments and enables a fully data-driven approach to H₂S management.
Team Member, Member of the BoD and Seed Investor
Jan 2020
The new contraception method - simple and reversible sterilisation for men.
Today, 27% of men worldwide use contraception in one form or another. Many users of contraception ask for an alternative to existing forms e.g. condom, birth control pills or surgery (vasectomy).
VasDeBlock is an alternative male contraception method that neither requires surgery nor holds hormones and which is far more practical than condoms. The method is simple and has a significantly lower cost than surgery. Another big advantage is that the fertility quite easily may be restablished.
VasDeBlock medical ApS has consulted with doctors in urology and medical device companies to devise a unique way to temporarily stop male fertility by blocking vas deferens and later to restablish normal fertility relatively easy. Doctors specializing in urology have not identified any basic flaws in the method and assume that it can be used in practice by all males.
In the Western world, the method must be seen as an alternative to well-known methods of contraception, including surgery which 2-5 million men and 6-10 million women undergo yearly.
The company is right now in a phase where the focus is on developing prototypes and conduct in-vivo testing to prove the concept. We are looking for financing from sources willing to contribute to the next steps. Financing may be in the form of grants, loans or direct investments.
Team Member and Seed Investor
Jan 2020
The new contraception method - simple and reversible sterilisation for men.
Today, 27% of men worldwide use contraception in one form or another. Many users of contraception ask for an alternative to existing forms e.g. condom, birth control pills or surgery (vasectomy).
VasDeBlock is an alternative male contraception method that neither requires surgery nor holds hormones and which is far more practical than condoms. The method is simple and has a significantly lower cost than surgery. Another big advantage is that the fertility quite easily may be restablished.
VasDeBlock medical ApS has consulted with doctors in urology and medical device companies to devise a unique way to temporarily stop male fertility by blocking vas deferens and later to restablish normal fertility relatively easy. Doctors specializing in urology have not identified any basic flaws in the method and assume that it can be used in practice by all males.
In the Western world, the method must be seen as an alternative to well-known methods of contraception, including surgery which 2-5 million men and 6-10 million women undergo yearly.
The company is right now in a phase where the focus is on developing prototypes and conduct in-vivo testing to prove the concept. We are looking for financing from sources willing to contribute to the next steps. Financing may be in the form of grants, loans or direct investments.
Seed Investor
Dec 2019
Medicortex Finland Oyj is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including traumatic brain injury (TBI) and concussion. One of the company's missions is to identify a new biomarker in order to reliably assess the severity and extent of brain injury. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a public limited company. Dr. Harel has a track record in business management and leadership of early-stage biotechnology companies.
----
Kuvaus suomeksi:
Medicortex Finland Oyj (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan tapaturmaisten aivovammojen (TBI) diagnostiikkaa ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.
Experience · 20 entries
All (20)
Investments (8)
Founder (3)
Board (1)
2025
Seed Investor
Feb 2025
CELCORE is a Danish life-science company at the
forefront of aesthetic medicine.
Our mission is to revolutionize skin rejuvenation by addressing aging at its biological core – rebuilding the skin’s natural framework at a cellular level for lasting results that go beyond temporary volume.
From our EU-licensed Tissue Establishment near Copenhagen, we harness the remarkable regenerative properties of human adipose tissue through two groundbreaking technology platforms.
ECM Technology Platform: Transforming adipose tissue into injectable treatments rich in collagen, elastin, and vital proteins for natural skin regeneration
Stem Cell Platform: Isolating and expanding mesenchymal stem cells for enhanced fat transfer procedures and research applications
Our proprietary technologies unlock the extraordinary potential of adipose tissue, creating advanced solutions for aesthetic medicine.
2023
Seed Investor
Jun 2023
Copenhagen Nanosystems (cphnano.com) is a Danish Labtech company that develops solutions for particle size analysis and UV-Vis spectroscopy.
We work with upgrading UV-Vis spectrophotometry across all brands to be at the forefront at the technology development.
We expand the functionality of existing spectrophotometers by developing plastic labware with nanotechnology and analyzing data in the cloud - leading to faster and more accurate results in the laboratory while lowering upfront investments.
The NanoCuvettes™ unlocks the full potential of the spectrophotometer and SpectroWorks™ optimizes and automizes your UV-Vis instrument workflow.
2022
Seed Investor
Nov 2022
GO-Pen is developing an affordable, reliable and sustainable insulin pen.
Our vision is to make a difference for the millions of people living with diabetes who currently cannot afford modern devices.
2020
S
Seed Investor
Aug 2020
We are on a mission to reinvent the microelectrochemical sensor and change the way hydrogen sulfide is reliably measured in industrial applications.
The SulfiLogger™ sensor provides the insights you need to take your H₂S management to the next level. Using these insights, you can optimize mitigation activities and better account for H₂S in the planning of sewer infrastructure projects.
The SulfiLogger™ sensor is the only affordable sensor that measures H₂S continuously in untreated wastewater and in wet process gases. It represents a radically new approach to measuring and monitoring H₂S in harsh environments and enables a fully data-driven approach to H₂S management.
Mentor and Team Member
Mar 2020
Welcome to the network of Venture Cup Experts 🌐
1. This network group exists for you and 200+ other members 👩🏻🏫
2. As a Venture Cup Expert, you now have this closed access to a large network of highly skilled business professionals, where the idea is that you can connect with other Venture Cup Experts and share best practices with each other, invite member/s for a cup of coffee, after work beer, post relevant events and other happenings 🍸
3. If you have any questions regarding mentoring, judging or business plan screenings, you can always try to post your question on the timeline, and see if a member can help you out. Or reach out privately 📣
4. Each year we invite all members for a physical event. In 2022 it will most likely be in the end of November ☑️
5. At last - Thank you Venture Cup Expert for supporting university entrepreneurship with your valuable time, know-how and industry expertise 🙏
The Venture Cup Experts (f. Startup Mentors) is initiative by Venture Cup Denmark, and sponsored by The Hempel Foundation 🧡
Contact email: experts@venturecup.dk
Show all 20 entries ↓
Investment activity
1995–2025 · 8 investments
Recent (last 2 years)Earlier
